Europe Should Move To Centralized Review Of All Drugs - CPMP's Winkler
Executive Summary
All new drugs in the EU should be licensed through a centralized procedure, Austrian regulator and CPMP member Hans Winkler suggested at a European Federation of Pharmaceutical Industries' Associations conference in London Nov. 20.